Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KR.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.53.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.9.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.47.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JQ.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDSNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LY.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.2.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.108NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.104NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.103NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HC.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used